Advertisement
Abivax S.A.

Abivax S.A. (ABVX) Stock Overview

Explore Abivax S.A.’s financial performance, market position, analyst ratings, and future outlook.

ABVX●NASDAQ
HealthcareBiotechnology
$104.93
$14.78(16.39%)
U.S. Market opens in 16h 7m
Advertisement

Abivax S.A. (ABVX)

Meyka AI Score

Z

Key Financials

Market Cap6.9B
P/E Ratio-15.85
EPS (TTM)$-5.37
ROE-1.65%
Fundamental Analysis

AI Price Forecasts

1 Month$119.07
3 Months$91.91
1 Year Target$135.50

ABVX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Abivax S.A. (ABVX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.44, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $135.50.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -15.85 and a market capitalization of 6.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
16.39%
5-Day Change
-19.66%
1-Month Change
-10.42%
3-Month Change
-10.14%
6-Month Change
-5.16%
Year-to-Date (YTD) Change
-22.19%
1-Year Change
1201.86%
3-Year Change
1164.22%
5-Year Change
1164.22%
All-Time (Max) Change
1164.22%

Contact Information

https://www.abivax.com
33 1 53 83 08 41
5, rue de la Baume, Paris, NaN, 75008

Company Facts

69 Employees
IPO DateOct 20, 2023
CountryFR
Actively Trading

Frequently Asked Questions